Article
The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment.
Integrative cancer therapies - 1 Mar 2017
Hung Hsiu-Ying, Tseng Yen-Han, Liao Chia-Miao, Chen Sung-Yi, Wu Ta-Peng, Lee Yu-Chin, Chen Yuh-Min
Abstract excerpt
BACKGROUND: Chinese herbal medicine (CHM) has been used for thousands of year in Eastern countries. First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment is the standard treatment in stage IV pulmonary adenocarcinoma patients who had tumor EGFR mutations. This study was to find the efficacy of CHM on lung cancer treatment. MATERIALS AND METHODS: We retrospectively reviewed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.